Drug data last refreshed 18h ago · AI intelligence enriched Yesterday
ALAVERT (loratadine) is a non-sedating second-generation H1-receptor antagonist antihistamine available as an orally disintegrating tablet. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic urticaria. The drug works by selectively blocking H1-receptors, reducing histamine-mediated allergic responses.
With LOE approaching and high competitive pressure (30/100), brand teams are likely consolidating and shifting focus to defensive positioning rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu
A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico
A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets
A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets
Worked on ALAVERT at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
ALAVERT represents a mature OTC/Rx franchise with minimal career growth potential due to approaching LOE and zero linked job postings. Professionals joining this product should expect a consolidation-focused, defensive commercial environment rather than opportunity for expansion or innovation.